Article info
PDFLiver
Original research
Selective internal radiation therapy (SIRT) for hepatocellular carcinoma (HCC): informing clinical practice for multidisciplinary teams in England
- Correspondence to Professor Helen L Reeves, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, Tyne and Wear, UK; h.l.reeves{at}ncl.ac.uk
Citation
Selective internal radiation therapy (SIRT) for hepatocellular carcinoma (HCC): informing clinical practice for multidisciplinary teams in England
Publication history
- Received February 9, 2022
- Accepted June 1, 2022
- First published June 30, 2022.
Online issue publication
January 23, 2024
Article Versions
- Previous version (7 December 2022).
- Previous version (7 December 2022).
- Previous version (7 December 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.